Pcas EBITDA per Share
Delisted·Dec 6, 2023
The EBITDA per Share of Pcas (PCA.PA) as of Aug 20, 2026 is -1.59 EUR. In the previous year, EBITDA per Share was -0.72 EUR — a change of 119.48% (lower).
Get this data via API
Financial Data API
EBITDA per Share
-1.59EUR
YoY
119.48%
Last updated:
EBITDA per Share of Pcas is 2026 -1.59 EUR. EBITDA per Share of Pcas was 2025 -0.72 EUR. It decreases by 119.48% lower compared to the previous year.
Access this data via the Eulerpool API
Pcas Stock analysis
What does Pcas do? Pcas SA is a French chemical company specializing in the development and production of chemical substances. It was founded in 1962 by a group of independent chemical engineers. The company has expanded its business areas over the years and now has four divisions: Materials Division, Fine Chemicals Division, Life Science Division, and Petrochemicals Division.
The Materials Division focuses on manufacturing organic and inorganic materials such as polymers and specialty chemicals used in various industries including automotive and construction.
The Fine Chemicals Division specializes in synthesizing pharmaceutical active ingredients used in medication production and new therapy development. Pcas SA offers a wide range of chemical compounds customized to customer needs.
The Life Science Division is involved in the development and production of cell-based products used in diagnostics and pharmaceutical research. This division produces enzymes, specialized cells, proteins, and reagents.
The Petrochemicals Division produces specialized polymer additives and tank cleaners used in petrochemical, refinery, and maritime industries.
All divisions of Pcas SA prioritize customer satisfaction and quality assurance by implementing environmental and sustainability standards.
The company is known for its ability to quickly and flexibly respond to customer needs and requirements, including production adjustments and the development of new products. Pcas SA invests in research and development, collaborating with leading research institutions and scientists to continuously improve and apply cutting-edge technologies.
In addition to the mentioned divisions, Pcas SA also produces a wide range of chemical intermediates and specialty chemicals used in various industries such as cosmetics, food, photovoltaic, and electronics.
Overall, Pcas SA is an innovative and versatile company known for its flexibility, quality assurance, and customer focus. It has earned a leading position in the international chemical industry through its high-quality products and services, as well as its commitment to sustainability and environmental protection. Pcas is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Pcas stock
EBITDA per Share of Pcas is -1.59 EUR in 2026.
EBITDA per Share of Pcas changed from -0.72 EUR to -1.59 EUR, representing a 119.48% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBITDA per Share Pcas since 2006 – with annual values, charts, and detailed analysis.
EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.
Access this data via the Eulerpool API
Income Statement — Pcas
All Key Metrics — Pcas
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth